-The Hindu Antibody prevalence data derived from serosurveys must be interpreted with caution and correction factors The theory behind population-based serological surveys (seroprevalence surveys or serosurveys) to detect the prevalence of Antibodies against COVID-19 is robust. Their purpose is to measure the proportion of a population already infected, as evidenced by antibody positivity. When applied on a national scale, a random sample of the entire population is tested. Then, the data are...
More »SEARCH RESULT
SARS-CoV-2 has infected less than 1% of sample population: ICMR survey -Maitri Porecha
-The Hindu Business Line Less than one per cent of the population surveyed by the Indian Council of Medical Research (ICMR) in 83 districts, is believed to be exposed to SARS-CoV-2 virus, which causes Covid-19. As very few persons have been exposed to the virus, the Centre warned on Thursday that a large proportion of the population is still vulnerable to get infected. As a result, the Centre has also stated...
More »Audit of bigotry: How Indian media vilified Tablighi Jamaat over coronavirus outbreak -Ayan Sharma & Chahak Gupta
-Newslaundry.com Communal hatred, fake news, conspiracy theories, misinformation, misreporting. The coverage of the Nizamuddin congregation had it all. Having recovered from Covid-19, more than 200 followers of the Tablighi Jamaat are donating plasma to Delhi’s hospitals. Blood plasma containing Antibodies against coronavirus from recovered patients is given to severely ill people to help them fight off the infection. It’s an experimental treatment known as convalescent plasma therapy. The donation by the Tablighis...
More »Covid vaccine could come in a year, but life-as-usual years away, says WHO chief scientist -Sandhya Ramesh
-ThePrint.in At ThePrint’s Off The Cuff, WHO chief scientist Soumya Swaminathan sought to bust many myths around Covid-19, including its rumoured origin in a Wuhan lab. Bengaluru: A vaccine for the Covid-19 could emerge in about a year, World Health Organisation (WHO) chief scientist Soumya Swaminathan has said, even as she sought to highlight the possibility of the novel coronavirus becoming a seasonal virus like the influenza, or an endemic infection. In conversation...
More »Delhi: Plasma therapy to be used on trial basis to treat COVID-19 patients
-The Indian Express The technique, also known as the convalescent plasma therapy, seeks to make use of the Antibodies developed in the recovered patient against the coronavirus. As Delhi’s coronavirus cases climbed to over 1,500, the state government on Wednesday announced that plasma enrichment technique would now be used to treat severely-ill COVID-19 patients on trial basis at a government hospital. Last week, Kerala became the first state to receive ICMR approval...
More »